Home > Boards > US Listed > Biotechs > Enanta Pharmaceuticals (ENTA)

Q4 earnings transcript- must read

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ECole Member Profile
 
Followed By 20
Posts 1,363
Boards Moderated 1
Alias Born 07/02/13
160x600 placeholder
Enanta Pharmaceuticals to Host Conference Call on August 5 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Third Quarter Ended June 30, 2021 Business Wire - 7/29/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/16/2021 4:07:39 PM
Enanta Pharmaceuticals Announces the Planned Retirement of Chief Medical Officer Nathalie Adda, M.D. Business Wire - 7/14/2021 5:30:00 PM
Enanta Pharma presents new EDP-721 data in HBV at EASL congress Seeking Alpha - 6/23/2021 3:38:34 AM
Enanta Pharmaceuticals Presents New Data for EDP-721, an Oral Hepatitis B Virus RNA Destabilizer, at the European Association... Business Wire - 6/23/2021 2:01:00 AM
Enanta Pharmaceuticals Reports Positive Data from Phase 1b Study of EDP-514, a Hepatitis B Virus (HBV) Core Inhibitor, in Vir... Business Wire - 6/22/2021 4:01:00 PM
Enanta Pharmaceuticals to Participate in Two Investor Conferences in June Business Wire - 6/10/2021 7:00:00 AM
Enanta Pharmaceuticals to Present Preclinical Data for EDP-721, its Novel Oral Hepatitis B Virus RNA Destabilizer, at the Int... Business Wire - 6/3/2021 7:00:00 AM
Enanta Pharmaceuticals to Present at the RBC Capital Markets Global Healthcare Conference Business Wire - 5/11/2021 7:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 5/10/2021 4:11:31 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2021 4:02:36 PM
Enanta Pharma shows positive effect in early-stage study for hep B therapy Seeking Alpha - 5/6/2021 4:26:52 PM
Enanta Pharma EPS misses by $0.12, misses on revenue Seeking Alpha - 5/6/2021 4:06:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2021 4:05:02 PM
Enanta Pharmaceuticals Reports Positive Data from Part 2 of its Phase 1b Study of EDP-514 in Chronic Hepatitis B Virus Patien... Business Wire - 5/6/2021 4:01:00 PM
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2021 with Webcast & Conference... Business Wire - 5/6/2021 4:01:00 PM
Enanta Pharma FQ2 2021 Earnings Preview Seeking Alpha - 5/5/2021 5:35:16 PM
Enanta to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended ... Business Wire - 4/29/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/5/2021 4:01:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2021 6:46:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2021 6:38:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2021 6:30:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2021 6:24:49 PM
Enanta Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire - 3/2/2021 7:01:00 AM
Enanta Pharmaceuticals to Present at SVB Leerink 10th Annual Global Healthcare Conference Business Wire - 2/18/2021 4:02:00 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences